HCAT - Health Catalyst, Inc. Stock Analysis | Stock Taper
Logo
Health Catalyst, Inc.

HCAT

Health Catalyst, Inc. NASDAQ
$1.24 0.41% (+0.01)

Market Cap $90.51 M
52w High $5.06
52w Low $0.95
P/E -0.48
Volume 1.32M
Outstanding Shares 73.59M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q4-2025 $74.68M $-46.83M $-91.03M -121.89% $-1.28 $44.65M
Q3-2025 $76.32M $55.33M $-22.23M -29.12% $-0.32 $-3.94M
Q2-2025 $80.72M $75.33M $-40.98M -50.76% $-0.59 $-22.43M
Q1-2025 $79.41M $56.41M $-23.74M -29.9% $-0.35 $-3.89M
Q4-2024 $79.61M $52.19M $-20.67M -25.97% $-0.33 $-2.48M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q4-2025 $95.73M $502.64M $256.86M $245.78M
Q3-2025 $91.54M $587.13M $255.21M $331.92M
Q2-2025 $97.34M $616.18M $268.63M $347.55M
Q1-2025 $341.97M $891.54M $514.73M $376.81M
Q4-2024 $392M $858.93M $493.72M $365.21M

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q4-2025 $-91.03M $9.91M $1.01M $-434K $10.51M $9.64M
Q3-2025 $-22.23M $-464K $-9.35M $-537K $-10.41M $-5.27M
Q2-2025 $-40.98M $-9M $-52.23M $-230.1M $-291.26M $-8.77M
Q1-2025 $-23.74M $280K $96.76M $-4.71M $92.32M $-390K
Q4-2024 $-20.67M $-3.53M $-112.75M $37.69M $-78.68M $-8.36M

Revenue by Products

Product Q1-2025Q2-2025Q3-2025Q4-2025
Recurring Technology
Recurring Technology
$50.00M $50.00M $50.00M $50.00M

Q4 2025 Earnings Call Summary

Read Call Summary

5-Year Trend Analysis

A comprehensive look at Health Catalyst, Inc.'s financial evolution and strategic trajectory over the past five years.

+ Strengths

Key strengths include a strong liquidity and net cash position, a healthy gross margin structure, and a differentiated healthcare analytics platform supported by deep domain expertise and high switching costs. The company’s technology roadmap, especially the Ignite platform and AI integration, aligns well with long-term trends toward data-driven healthcare and measurable performance improvement. Its blend of software and services helps embed it deeply in client operations and supports long-term relationships.

! Risks

The most significant risks are persistent operating and net losses, only modest positive operating cash flow, and ongoing cash burn when acquisitions and capital returns are considered. Heavy reliance on goodwill and other intangibles could lead to write-downs if growth or profitability falls short. Competitive pressures from large electronic health record vendors, other analytics specialists, and big technology firms, combined with the possibility of clients building in-house solutions, add strategic risk. If financial performance does not improve, the company may face tougher choices about spending, acquisitions, or raising additional capital.

Outlook

The overall outlook is that of a company with attractive strategic positioning and technology, but with execution and financial hurdles still to clear. Success will likely depend on completing the transition to the Ignite platform, demonstrating consistent margin improvement, and showing that innovation in AI and analytics can translate into scalable, profitable growth. As long as liquidity remains strong, the firm has room to pursue this path, but the window is not unlimited, making the next few years particularly important for validating its long-term business model.